Fusion Antibodies plc (AIM:FAB)
London · Delayed Price · Currency is GBP · Price in GBX 12.26
-0.25 (-1.96%)
May 6, 2026, 4:15 PM GMT
Fusion Antibodies Market Cap
Fusion Antibodies has a market cap or net worth of 15.63 million as of May 6, 2026. Its market cap has increased by 104.31% in one year.
Market Cap
15.63M
Enterprise Value
15.76M
Revenue
1.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
12.26
Market Cap Chart
Since December 18, 2017, Fusion Antibodies's market cap has decreased from 27.28M to 15.63M, a decrease of -42.72%. That is a compound annual growth rate of -6.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 15.63M | -1.79% |
| Dec 31, 2025 | 15.91M | 135.22% |
| Dec 31, 2024 | 6.76M | 167.72% |
| Dec 29, 2023 | 2.53M | -78.42% |
| Dec 30, 2022 | 11.71M | -59.09% |
| Dec 31, 2021 | 28.62M | -9.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 18, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hemogenyx Pharmaceuticals | 43.47M |
| Poolbeg Pharma | 30.32M |
| Sareum Holdings | 27.96M |
| ImmuPharma | 25.83M |
| SkinBioTherapeutics | 25.27M |
| Arecor Therapeutics | 24.92M |
| Aptamer Group | 21.59M |
| IXICO | 14.99M |